One-stop-platform for plant-based nutraceuticals

2 Oct 2019

In 2020, nutra brands will look to ensure they have plant-based options across all product classes with many actively looking to move entire portfolios plant-based.

Ahead of SupplySide West, Sirio Pharma unveils full spectrum of one-stop-services for all plant-based products and announces plans for 2020.

One-stop-platform for plant-based nutraceuticals

The company is using the event to actively promote its integrated solutions in plant-based nutraceuticals. Sirio offers plant-based solutions across all dosage form platforms. The Sirio Group is able to rapidly develop customer products across the entire spectrum of delivery formats – including gummies, softgels, and tablets. The company also offers organic softgels at Ayanda’s European site – a Sirio Group company – with plans underway to get organic certification across all sites.

“What you see in the wider market are some contract providers across formats such as tablets and softgels working on plant-based solutions here and there. Sirio is leading the market delivering plant-based solutions across all delivery formats – gummies, softgels, tablets, powders and liquids. Sirio has a wide range of capabilities and, just as crucially, experience formulating these compounds for customers globally,” said Doug Brown, Director Americas at Sirio Pharma.

The company anticipates that many customers, particularly those in North America and Europe, are now looking at ways to move their entire product portfolios across to plant-based solutions and using one contract provider presents a good number of advantages.

Brown added: “Sirio presents a one-stop-shop for plant-based product solutions. It is strategically important that customers transitioning entire lines to plant-based formats know that there is a trusted, experienced partner in Sirio that can deliver end-to-end development, formulation and manufacturing services for them delivered anywhere in the world on time and in full.”

The company’s plant-based one-stop-services focus at SupplySide West mark the start of an extended push to global customers, with Sirio also introducing the platform to European customers at CPhI Worldwide in November.

Sirio anticipates that while the plant-based movement has been building for a number of years, 2020 will be the year that companies look to ensure they have plant-based options across all product classes.

Significantly, this will have implications for the capabilities needed from CDMO partners. Sirio entered this market early on with its patented technologies for softgels and pectin-based gummies. With many new customized products potentially needed, the company predicts an extremely large demand for full-service plant-based capabilities.

Read More

Related news

Industry on the brink of a new age of smart pharma manufacturing

Industry on the brink of a new age of smart pharma manufacturing

27 Sep 2019

Report predicts tomorrow’s biggest industry winners will need to invest now ahead of the curve.

Read more 
Huge boom in Korean Pharma reported at CPhI Korea

Huge boom in Korean Pharma reported at CPhI Korea

20 Sep 2019

Event sees new Memorandum of Understanding signed by PROLMED and KPTA.

Read more 
Drivers behind Saudi Arabia’s forecast 10.74 $billion 2022 market

Drivers behind Saudi Arabia’s forecast 10.74 $billion 2022 market

9 Sep 2019

Growing population, increase in non-communicable diseases and major investment in new hospitals, clinics and treatments driving growth.

Read more 
Take part in pharma’s largest reputation survey

Take part in pharma’s largest reputation survey

6 Sep 2019

Use your voice to shape CPhI Worldwide's third annual global survey of the major trends, changes and developments in the industry.

Read more 
Meet Avivia / Excipia at booth B56 Hall 12.1 CPhI Frankfurt 2019

Meet Avivia / Excipia at booth B56 Hall 12.1 CPhI Frankfurt 2019

29 Aug 2019

Meet Avivia at booth B56 Hall 12.1 CPhI Frankfurt 2019

Read more 
Switzerland overtakes Germany as Europe’s biggest drug delivery innovator

Switzerland overtakes Germany as Europe’s biggest drug delivery innovator

16 Aug 2019

Pipeline of new drugs has helped drive increased innovation in packaging and drug delivery devices.

Read more 
Growing domestic manufacturing creates new opportunities for international pharma in the Middle East

Growing domestic manufacturing creates new opportunities for international pharma in the Middle East

5 Aug 2019

Opportunities abound at CPhI MEA and experts anticipate regional generic companies acting as CMOs for international companies looking to enter the region.

Read more 
Drive for generics sees Korea increasingly attractive to international pharma

Drive for generics sees Korea increasingly attractive to international pharma

31 Jul 2019

Korean companies are opening more facilities overseas and using CPhI Korea to look for new international partners.

Read more 
Huge CPhI & P-MEC China a direct result of surging manufacturing

Huge CPhI & P-MEC China a direct result of surging manufacturing

22 Jul 2019

Great Hall of China: Informa adds additional capacity to Asia’s largest pharma event with record 66,000+ visits from 141 countries.

Read more 
Fresh data on protein interactions in Alzheimer’s disease

Fresh data on protein interactions in Alzheimer’s disease

2 Jul 2019

Demonstrates the unique ability of diffusional sizing to assess protein binding in-solution and for difficult-to-study systems.

Read more